Company Filing History:
Years Active: 1993-1995
Title: Innovator Spotlight: Susan M. Papile
Introduction
Susan M. Papile, an accomplished inventor based in Blue Bell, PA, has made significant contributions in the field of pharmaceutical technology. With two patents to her name, she specializes in developing innovative solutions that enhance the efficacy and user experience of chewable medicament tablets.
Latest Patents
Her latest patents focus on taste-masking coatings for preparing chewable pharmaceutical tablets. The first patent describes a process for creating chewable medicament tablets from coated rotogranules, which contain a granulation mixture of a medicament (such as famotidine), a binder (like hydroxypropyl methylcellulose), and a carrier (such as lactose). These rotogranules are then coated with cellulose acetate, cellulose acetate butyrate, or a combination thereof to mask the taste of the medicament.
The second patent also pertains to chewable medicament tablets, utilizing coated rotogranules formed from a mixture of medicament, binder (in this case, polyvinylpyrrolidone), and carrier (again, lactose). These rotogranules are coated with a combination of cellulose acetate, cellulose acetate butyrate, and polyvinylpyrrolidone, offering a method for providing taste masking that significantly improves patient compliance.
Career Highlights
Susan is currently associated with McNeil-PPC, Inc., where her expertise in formulation science plays a critical role in the development of effective pharmaceutical products. Her innovative approaches and attention to detail demonstrate her commitment to improving the medicinal experience for patients.
Collaborations
Throughout her career, Susan has collaborated with notable professionals such as Edward J. Roche and Eleanor M. Freeman. These partnerships have fostered a dynamic environment for research and development, enhancing the overall quality of their projects and patents.
Conclusion
In summary, Susan M. Papile stands out as a pioneering inventor whose contributions to the field of pharmaceuticals have the potential to transform patient experiences with medicament tablets. Her dedication to innovation and collaboration exemplifies the spirit of progress in the industry.